(Q38359209)

2 September 2017

1 reference

title

Circulating tumor cells in lung cancer: detection methods and clinical applications (English)

1 reference

2 September 2017

1 reference

Na Yu

1

1 reference

2 September 2017

Jia Zhou

series ordinal

2

1 reference

2 September 2017

Fang Cui

series ordinal

3

1 reference

2 September 2017

Xiaokui Tang

series ordinal

4

1 reference

2 September 2017

19 February 2015

1 reference

2 September 2017

1 reference

2 September 2017

193

1 reference

2 September 2017

2

1 reference

2 September 2017

157-171

1 reference

https://scigraph.springernature.com/pub.10.1007/s00408-015-9697-7

2 September 2017

0 references

cites work

Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected]

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Mobilization of viable tumor cells into the circulation during radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Lung cancer circulating tumor cells isolated by the EpCAM-independent enrichment strategy correlate with Cytokeratin 19-derived CYFRA21-1 and pathological staging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Molecular markers detecting circulating melanoma cells by reverse transcription polymerase chain reaction: methodological pitfalls and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Detection of the circulating tumor cells in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Circulating tumor cell detection in advanced non-small cell lung cancer patients by multi-marker QPCR analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Improvement of specific detection of circulating tumor cells using combined CD45 staining and fluorescence in situ hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Detection of micrometastases in peripheral blood of non-small cell lung cancer with a refined immunomagnetic nanoparticle enrichment assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Dissecting the metastatic cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Circulating tumor cell as a diagnostic marker in primary lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Prognostic impact of circulating tumor cells in patients with small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Detection of circulating tumor cells by reverse transcriptase-polymerase chain reaction in patients with resectable non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Phase II trial of Belagenpumatucel-L, a TGF-beta2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

LUNX mRNA-positive cells at different time points predict prognosis in patients with surgically resected nonsmall cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Detection of circulating tumor cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: a potential hazard for intraoperative hematogenous tumor cell dissemination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Preoperative evidence of circulating tumor cells by means of reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non-small cell lung cancer: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Prognostic significance of circulating tumor cells in advanced non-small cell lung cancer patients treated with docetaxel and gemcitabine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Relationship of circulating tumor cells to the effectiveness of cytotoxic chemotherapy in patients with metastatic non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Detection of mutations in EGFR in circulating lung-cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Decreased adhesiveness, resistance to anoikis and suppression of GRP94 are integral to the survival of circulating tumor cells in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Perforin-dependent direct cytotoxicity in natural killer cells induces considerable knockdown of spontaneous lung metastases and computer modelling-proven tumor cell dormancy in a HT29 human colon cancer xenograft mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Innovative method using circulating tumor cells for prediction of the effects of induction therapy on locally advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

An observational study of circulating tumor cells and (18)F-FDG PET uptake in patients with treatment-naive non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

SCG3 transcript in peripheral blood is a prognostic biomarker for REST-deficient small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Novel molecular tumor cell markers in regional lymph nodes and blood samples from patients undergoing surgery for non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-015-9697-7

Detection of amplifiable messenger RNA in the serum of patients with lung cancer.

21 January 2018

1 reference

12 December 2020

Fluctuation of circulating tumor cells in patients with lung cancer by real-time fluorescent quantitative-PCR approach before and after radiotherapy

1 reference

12 December 2020

Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription-PCR assay

1 reference

12 December 2020

[Clinical significance of expressions of tumor markers in peripheral blood in non-small cell lung cancer]

1 reference

12 December 2020

TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients

1 reference

12 December 2020

Combination of four gene markers to detect circulating tumor cells in the peripheral blood of patients with advanced lung adenocarcinoma using real-time PCR

1 reference

12 December 2020

Clinical significance of circulating tumor cells and free DNA in non-small cell lung cancer

1 reference

12 December 2020

CK-19 mRNA-positive cells in peripheral blood predict treatment efficacy and survival in small-cell lung cancer patients

1 reference

12 December 2020

Prognostic value of EpCAM/MUC1 mRNA-positive cells in non-small cell lung cancer patients

1 reference

12 December 2020

[Clinical Significance of CK20, CK19, CEA mRNAs in Peripheral Blood from Lung Cancer Patients.].

1 reference

12 December 2020

Effect of circulating tumor cells combined with negative enrichment and CD45-FISH identification in diagnosis, therapy monitoring and prognosis of primary lung cancer

1 reference

12 December 2020

Meta-analysis of circulating tumor cells as a prognostic marker in lung cancer

1 reference

12 December 2020

[Clinical significance of enrichment and detection of circulating tumor cells in NSCLC patients with immunomagnetic beads].

1 reference

12 December 2020

Detection of micrometastases in lung cancer with magnetic nanoparticles and quantum dots

1 reference

12 December 2020

Preliminary investigation of the clinical significance of detecting circulating tumor cells enriched from lung cancer patients

1 reference

12 December 2020

Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer

1 reference

12 December 2020

[Detection of circulating tumor cells by nano-immunomagnetic enrichment in early lung cancer]

1 reference

12 December 2020

Circulating tumor cells in peripheral blood caused by surgical manipulation of non-small-cell lung cancer: pilot study using an immunocytology method

1 reference

12 December 2020

Circulating tumor cells in pulmonary venous blood of primary lung cancer patients

1 reference

12 December 2020

Multigene real-time PCR detection of circulating tumor cells in peripheral blood of lung cancer patients

1 reference

12 December 2020

[Expression and clinical significance of surfactant protein D mRNA in peripheral blood of lung cancer patients]

1 reference

12 December 2020

10.1007/S00408-015-9697-7

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference